Clinical Trials
84 trialsBupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
LETSGO
Sorlandet Hospital HF
GYNCOG
Northwestern University
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Simulation Supported Vulva Cancer and Self-Examination on Knowledge, Skills and Attitude
Trakya University
EARN
Washington University School of Medicine
Gynecological Sentinel Lymph Nodes CEUS
Thomas Jefferson University
CNSI-Fe(II)
Sichuan Enray Pharmaceutical Sciences Company
P-COC
University of Alabama at Birmingham
PEVOsq
UNICANCER
PRECursOr
Indiana University
RACE
Barbara Ann Karmanos Cancer Institute
Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid
Gene Surgery LLC
Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer
Ohio State University Comprehensive Cancer Center
Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients
Afyonkarahisar Health Sciences University
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Shanghai Bovax Biotechnology Co., Ltd.
Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers
M.D. Anderson Cancer Center
Self-Advocacy Serious Game in Advanced Cancer
University of Pittsburgh
Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study
University of Manchester
Clinical Implementation of Surface-guided Radiation Therapy in Vulvar Cancer
Peking Union Medical College Hospital
AMIGO
Dana-Farber Cancer Institute
A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine
Beijing Health Guard Biotechnology, Inc
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
Beijing Health Guard Biotechnology, Inc
GASVERT
Institut de Cancérologie de Lorraine
DUET-2
Xencor, Inc.
A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)
Merck Sharp & Dohme LLC
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
Ohio State University Comprehensive Cancer Center
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Shanghai Bovax Biotechnology Co., Ltd.
Effectiveness of an App Intervention to Reduce Postsurgical Symptom Distress in Patients With Vulvar Neoplasia
St.Gallen University of Applied Sciences
CaptHPV
Institut de Cancérologie de Lorraine
Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy
GOG Foundation
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Women's College Hospital
HIFU-Gynae
Institute of Cancer Research, United Kingdom
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
Abramson Cancer Center at Penn Medicine
V503-017
Merck Sharp & Dohme LLC
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Shanghai Bovax Biotechnology Co., Ltd.
Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)
Merck Sharp & Dohme LLC
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
University of Wisconsin, Madison
Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention
Boston Medical Center
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Albert Einstein College of Medicine
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
University of Michigan
Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
Alliance for Clinical Trials in Oncology
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
Merck Sharp & Dohme LLC
A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)
Merck Sharp & Dohme LLC
GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)
Merck Sharp & Dohme LLC
Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
Memorial Sloan Kettering Cancer Center
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
Ohio State University Comprehensive Cancer Center
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Masonic Cancer Center, University of Minnesota
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
Masonic Cancer Center, University of Minnesota
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
GOG Foundation